Any current/future new fundraising through debt or equity?

There is no explicit mention of any current or future fundraising through debt or equity in the call. The company highlights strong cash and cash equivalents of INR209 crores, providing significant financial flexibility. They emphasize disciplined management of working capital (173 days) and focus on strategic capital allocation. Management discusses planned capex of INR40-50 crores for existing facility upgrades and INR150-180 crores for a new greenfield project but does not specify funding sources. No plans for raising funds via equity or debt were indicated; the company relies on existing f

Any current/future capex/capital investment/strategic investment?

Standard Glass Lining Technology Limited is investing INR40-50 crores over the next 1 to 1.5 years to mechanize and automate existing manufacturing facilities, including adding robots and upgrading processes. A new greenfield project is underway with planned capital expenditure of INR150-180 crores for a heavy engineering facility featuring 100 mm fabrication thickness and 110-ton crane capacity, expected to be completed in 15-18 months. The company is expanding capacity for shell and tube glass lining heat exchangers to produce up to 300 units monthly starting January 2026, to drive growth.

Future growth expectations in sales/revenue/volumes?

The company expects steady year-on-year revenue growth of 20% to 25% over the next several years. Driven by increasing enquiries, especially from Pharma CDMO clients, with no expected slowdown. Expansion in product lines, capacities, and automation efforts will support growth. New facility and capacity enhancements aim to nearly double revenue potential, targeting INR2,000 crores top line with current and new facilities combined. Export revenues expected to rise from current 13%-15% to 30%-40% in 5-6 years, enhancing overall growth and profitability. Shell and tube glass lining heat

Future growth expectations in earnings/operating earnings/profits/EPS?

Management expects steady year-on-year growth of 20% to 25% in revenue, driven by increased orders from Pharma CDMO and specialty chemicals sectors. EBITDA margin expansion was aided by better pricing, cost optimizations, and increased exports; export EBITDA contribution is around 25%. Export revenue is targeted to increase from 13%-15% currently to 30%-40% over the next 5-6 years, supporting margin improvement. Capacity expansions including automation and a new greenfield facility expected to triple manufacturing capacity are underway, enabling revenue potential of INR2,000 crores and beyond.

Current/ Expected Orderbook/ Pending Orders?

The company does not follow an order book disclosure philosophy and hence does not officially disclose the order book. For the current year, they mention being almost full in terms of order capacity ("this year, we are completely almost full"). Order inflow from international markets is reported as very good this year. The company is experiencing increased enquiries and orders, especially from pharma and specialty chemicals sectors. They are planning significant capacity expansions to meet growing demand, including new facilities and automation. Shell and tube heat exchanger product line is ex

IN US

Sale is live|00:00:00left today

Standard Engineering Technology LtdQ2 FY25Industrial Manufacturing

Standard Engineering Technology Ltd Q2 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹224P/E: 37.0Market Cap: ₹2.8K CrSector: Industrial Manufacturing

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2

→The company expects steady year-on-year revenue growth of 20% to 25% over the next several years.
→Driven by increasing enquiries, especially from Pharma CDMO clients, with no expected slowdown.
→Expansion in product lines, capacities, and automation efforts will support growth.
→New facility and capacity enhancements aim to nearly double revenue potential, targeting INR2,000 crores top line with current and new facilities combined.
→Export revenues expected to rise from current 13%-15% to 30%-40% in 5-6 years, enhancing overall growth and profitability.
→Shell and tube glass lining heat exchanger production capacity increasing to 300 units per month by early 2026, key growth driver.
→Continued strategic focus on high-margin product segments and international market penetration supports sustained volume growth.

Margin guidance

Category 3

→Management expects steady year-on-year growth of 20% to 25% in revenue, driven by increased orders from Pharma CDMO and specialty chemicals sectors.
→EBITDA margin expansion was aided by better pricing, cost optimizations, and increased exports; export EBITDA contribution is around 25%.
→Export revenue is targeted to increase from 13%-15% currently to 30%-40% over the next 5-6 years, supporting margin improvement.
→Capacity expansions including automation and a new greenfield facility expected to triple manufacturing capacity are underway, enabling revenue potential of INR2,000 crores and beyond.
→Full-fledged sales of shell and tube glass lining heat exchangers starting June 2026 expected to drive growth and margins.
→Working capital days targeted to be reduced to 150 days to improve cash flows.
→Overall, management remains confident of maintaining 20%-25% revenue growth with sustainable EBITDA margins and enhanced profitability in coming years.

3 more insights locked — sign up free to unlock

Fundraise plans

→There is no explicit mention of any current or future fundraising through debt or equity in the call.
→The company highlights strong cash and cash equivalents of INR209 crores, providing significant financial flexibility.
→They emphasize disciplined management of working capital (173 days) and focus on strategic capital allocation.
→Management discusses planned capex of INR40-50 crores for existing facility upgrades and INR150-180 crores for a new greenfield project but does not specify funding sources.
→No plans for raising funds via equity or debt were indicated; the company relies on existing financial strength and internal accruals for expansions.
→They remain open to M&A if opportunities arise but provided no indication of requiring external funding for such activities.

Order book

Yes

→The company does not follow an order book disclosure philosophy and hence does not officially disclose the order book.
→For the current year, they mention being almost full in terms of order capacity ("this year, we are completely almost full").
→Order inflow from international markets is reported as very good this year.
→The company is experiencing increased enquiries and orders, especially from pharma and specialty chemicals sectors.
→They are planning significant capacity expansions to meet growing demand, including new facilities and automation.
→Shell and tube heat exchanger product line is expected to be a key growth driver starting full-fledged sales from June 2026.

Capex plans

Yes

→Standard Glass Lining Technology Limited is investing INR40-50 crores over the next 1 to 1.5 years to mechanize and automate existing manufacturing facilities, including adding robots and upgrading processes.
→A new greenfield project is underway with planned capital expenditure of INR150-180 crores for a heavy engineering facility featuring 100 mm fabrication thickness and 110-ton crane capacity, expected to be completed in 15-18 months.
→The company is expanding capacity for shell and tube glass lining heat exchangers to produce up to 300 units monthly starting January 2026, to drive growth.
→Additional investments are planned to increase manufacturing capacity threefold, including automation, polishing, welding improvements, and new facility modifications.
→No major capex planned for the U.S. subsidiary in South Carolina; it will act mainly as a stock and service point initially.
→Future M&A opportunities will be considered if the right targets emerge.

How does Standard Engineering Technology Ltd rank vs peers in Industrial Manufacturing?

Pro feature

1Standard Engineering Technology Ltd

Rev 2Mar 3

See full Industrial Manufacturing sector rankings

Want more stocks like Standard Engineering Technology Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio